首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1417397

膀胱癌檢測套件的全球市場：趨勢、預測和競爭分析（~2030 年）

Bladder Cancer Detective Kit Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2024年01月29日 | 出版商:

Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

膀胱癌檢測試劑套件的趨勢與預測

2030年，全球膀胱癌檢測套件市場規模預計將達4億美元，2024年至2030年年複合成長率為11.8%。市場的主要促進因素是膀胱癌盛行率的增加、醫療保健成本的上升以及菸草消費量的增加。由於醫院/診所和診斷中心市場的機會，全球膀胱癌檢測套件市場的未來前景看好。

膀胱癌檢測套件市場洞察

Lucintel 預計螢光原位雜合反應在預測期內仍將是最大的細分市場。在該領域使用的新尿液檢查技術使用直接標記的螢光DNA 探針來尋找尿路上皮細胞（包括尿液）的遺傳異常。

由於全球醫院基礎設施的進步，醫院和診所將繼續成為市場的最大部分。

由於該地區膀胱癌發生率不斷上升，北美在預測期內仍將是最大的地區。

常問問題

Q1.市場規模有多大？

A1. 到2030年，全球膀胱癌檢測套件市場預計將達到4億美元。

Q2.市場成長預測如何？

A2. 2024年至2030年，全球膀胱癌檢測套件市場預計年複合成長率為11.8%。

Q3.影響市場成長的主要促進因素有哪些？

A3. 市場的主要驅動力是膀胱癌盛行率的增加、醫療保健成本的上升以及菸草消費量的增加。

Q4.市場的主要細分市場是什麼？

A4. 由於醫院和診所市場以及診斷中心市場的機會，膀胱癌檢測試劑套件市場的未來性廣闊。

Q5.市場上主要企業有哪些？

A5.主要膀胱癌檢測套件公司如下。

Abbott Laboratories
Xiamen Biotime Biotechnology
Abingdon Health
Ameritek
Alfa Scientific Designs
NanoEnTek
Exact Sciences
Hubei Jinjian Biology
Nanjing Liming Bio-Products
Diagnosis

Q6.未來最大的細分市場是什麼？

A6.Lucintel表示，螢光原位雜合反應是該領域使用的一種新的尿液檢查技術，利用直接標記的螢光DNA探針來檢查尿路上皮細胞（包括尿液）的遺傳異常。我們預計它在預測期內仍將是最大的細分市場。

Q7. 未來五年預計哪個地區將成為最大的市場？

A7. 隨著膀胱癌發生率的增加，北美在預測期內仍是最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 允許 10% 的客製化，無需額外費用。

宏觀經濟趨勢（2018-2023）與預測（2024-2030）
全球膀胱癌檢測套件市場趨勢（2018-2023）與預測（2024-2030）
全球膀胱癌檢測套件市場：依技術分類
- 螢光原位雜合反應
- 酵素結合免疫吸附檢測法
- 其他
全球膀胱癌檢測套件市場：依最終用途產業
- 醫院/診所
- 診斷中心
- 其他

第4章市場趨勢與預測分析：按地區（2018-2030）

全球膀胱癌檢測套件市場：按地區
北美洲
歐洲
亞太地區
其他地區

第5章競爭分析

產品系列分析
營運整合
波特五力分析

第6章成長機會與策略分析

成長機會分析
- 依技術
- 按最終用途行業
- 按地區
全球膀胱癌檢測套件市場新趨勢
戰略分析
- 新產品開發
- 全球膀胱癌檢測套件市場產能擴張
- 全球膀胱癌檢測套件市場的合併、收購和合資企業
- 認證和許可

第7章主要企業概況

Abbott Laboratories
Xiamen Biotime Biotechnology
Abingdon Health
Ameritek
Alfa Scientific Designs
NanoEnTek
Exact Sciences
Hubei Jinjian Biology
Nanjing Liming Bio-products
Diagnosis

簡介目錄

Bladder Cancer Detective Kit Trends and Forecast

The future of the global bladder cancer detective kit market looks promising with opportunities in the hospitals & clinics and diagnostic centers markets. The global bladder cancer detective kit market is expected to reach an estimated $0.4 billion by 2030 with a CAGR of 11.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of bladder cancer, escalating healthcare expenses, and the growing consumption of cigarettes and tobacco.

A more than 150-page report is developed to help in your business decisions.

Bladder Cancer Detective Kit by Segment

The study includes a forecast for the global bladder cancer detective kit by technology, end use industry, and region.

Bladder Cancer Detective Kit Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

Fluorescence In Situ Hybridization
Enzyme-Linked Immunosorbent Assay
Others

Bladder Cancer Detective Kit Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

Hospitals & Clinics
Diagnostic Centers
Others

Bladder Cancer Detective Kit Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Bladder Cancer Detective Kit Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bladder cancer detective kit companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bladder cancer detective kit companies profiled in this report include-

Abbott Laboratories
Xiamen Biotime Biotechnology
Abingdon Health
Ameritek
Alfa Scientific Designs
NanoEnTek
Exact Sciences
Hubei Jinjian Biology
Nanjing Liming Bio-Products
Diagnosis

Bladder Cancer Detective Kit Market Insights

Lucintel forecasts that fluorescence in situ hybridization will remain the largest segment over the forecast period due to novel urine testing technique used in this field looks for genetic abnormalities in pee-containing urothelial cells by using fluorescent DNA probes that have been directly labeled.

Within this market, hospitals & clinics will remain the largest segment due to advancements in hospital infrastructure worldwide.

North America will remain the largest region over the forecast period due to growing incidence of bladder cancer in the area.

Features of the Global Bladder Cancer Detective Kit Market

Market Size Estimates: Bladder cancer detective kit market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bladder cancer detective kit market size by technology, end use industry, and region in terms of value ($B).

Regional Analysis: Bladder cancer detective kit market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technology, end use industry, and regions for the bladder cancer detective kit market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bladder cancer detective kit market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the bladder cancer detective kit market size?

Answer: The global bladder cancer detective kit market is expected to reach an estimated $0.4 billion by 2030.

Q2. What is the growth forecast for bladder cancer detective kit market?

Answer: The global bladder cancer detective kit market is expected to grow with a CAGR of 11.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the bladder cancer detective kit market?

Answer: The major drivers for this market are increasing prevalence of bladder cancer, escalating healthcare expenses, and the growing consumption of cigarettes and tobacco.

Q4. What are the major segments for bladder cancer detective kit market?

Answer: The future of the bladder cancer detective kit market looks promising with opportunities in the hospitals & clinics and diagnostic centers markets.

Q5. Who are the key bladder cancer detective kit market companies?

Answer: Some of the key bladder cancer detective kit companies are as follows.

Abbott Laboratories
Xiamen Biotime Biotechnology
Abingdon Health
Ameritek
Alfa Scientific Designs
NanoEnTek
Exact Sciences
Hubei Jinjian Biology
Nanjing Liming Bio-Products
Diagnosis

Q6. Which bladder cancer detective kit market segment will be the largest in future?

Answer: Lucintel forecasts that fluorescence in situ hybridization will remain the largest segment over the forecast period due to novel urine testing technique used in this field looks for genetic abnormalities in pee-containing urothelial cells by using fluorescent DNA probes that have been directly labeled.

Q7. In bladder cancer detective kit market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing incidence of bladder cancer in the area.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the bladder cancer detective kit market by technology (fluorescence in situ hybridization, enzyme-linked immunosorbent assay, and others), end use industry (hospitals & clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Bladder Cancer Detective Kit Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Bladder Cancer Detective Kit Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Bladder Cancer Detective Kit Market by Technology
- 3.3.1: Fluorescence In Situ Hybridization
- 3.3.2: Enzyme-Linked Immunosorbent Assay
- 3.3.3: Others
3.4: Global Bladder Cancer Detective Kit Market by End Use Industry
- 3.4.1: Hospitals & Clinics
- 3.4.2: Diagnostic Centers
- 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Bladder Cancer Detective Kit Market by Region
4.2: North American Bladder Cancer Detective Kit Market
- 4.2.2: North American Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others
4.3: European Bladder Cancer Detective Kit Market
- 4.3.1: European Bladder Cancer Detective Kit Market by Technology: Fluorescence In Situ Hybridization, Enzyme-Linked Immunosorbent Assay, and Others
- 4.3.2: European Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others
4.4: APAC Bladder Cancer Detective Kit Market
- 4.4.1: APAC Bladder Cancer Detective Kit Market by Technology: Fluorescence In Situ Hybridization, Enzyme-Linked Immunosorbent Assay, and Others
- 4.4.2: APAC Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others
4.5: ROW Bladder Cancer Detective Kit Market
- 4.5.1: ROW Bladder Cancer Detective Kit Market by Technology: Fluorescence In Situ Hybridization, Enzyme-Linked Immunosorbent Assay, and Others
- 4.5.2: ROW Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Bladder Cancer Detective Kit Market by Technology
- 6.1.2: Growth Opportunities for the Global Bladder Cancer Detective Kit Market by End Use Industry
- 6.1.3: Growth Opportunities for the Global Bladder Cancer Detective Kit Market by Region
6.2: Emerging Trends in the Global Bladder Cancer Detective Kit Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Bladder Cancer Detective Kit Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bladder Cancer Detective Kit Market
- 6.3.4: Certification and Licensing